Ascentifi
VC Fund
Galway, Ireland
Ascentifi is a VC fund in Galway focused on Health Care and Medical Device. Ascentifi was founded to make the start-up ecosystem more efficient.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Ascentifi invests in
Stages Ascentifi invests in
Countries Ascentifi invests in
Round sizes
Round size
- Seed
- $2.3M–$11M
- Series A
- $9.2M–$34M
- Venture - Series Unknown
- $3M–$3.5M
Investment Focus
Industry
- Health Care 5 (56%)
- Medical Device 4 (44%)
- Medical 2 (22%)
- Fitness 1 (11%)
- Hospital 1 (11%)
Stage
- Seed 3 (33%)
- Series A 2 (22%)
- Venture - Series Unknown 2 (22%)
- Series B 1 (11%)
- Funding Round 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance. | $3M / Venture - Series Unknown / Apr 08, 2026 | ||
| CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation | $16M / Series B / Aug 07, 2024 | ||
| Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance. | $2.3M / Seed / May 08, 2024 | ||
| X-BOLT Orthopaedics developed a novel expanding bolt device, with associated implants and instrumentation systems, for internal bone fixation in osteoporotic hip fractures. X-BOLT hip plating and nailing systems allow surgeons choice to treat all morphologies of proximal femoral fractures. | $3.5M / Venture - Series Unknown / Oct 29, 2023 | ||
| It has been estimated that up to 25% of diabetics will develop a foot ulcer at some point in their life. One of the main causes is peripheral neuropathy, which results in a patient losing sensation in their feet. Of the millions who develop ulcers every year, hundreds of thousands will require amputation due to infection. In 2014, Ireland recordedan increase in the number of amputations as a result of diabetes, with 8 limbs being lost every week. | $11.5M / Mar 31, 2023 | ||
| It has been estimated that up to 25% of diabetics will develop a foot ulcer at some point in their life. One of the main causes is peripheral neuropathy, which results in a patient losing sensation in their feet. Of the millions who develop ulcers every year, hundreds of thousands will require amputation due to infection. In 2014, Ireland recordedan increase in the number of amputations as a result of diabetes, with 8 limbs being lost every week. | $11.4M / Seed / Mar 31, 2023 | ||
| CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation | $9.2M / Series A / Feb 04, 2022 | ||
| ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. | $34.1M / Series A / Jan 11, 2022 | ||
| Tympany is a platform for performing minimally invasive ear surgeries, reducing unnecessary mastoidectomys and improving outcomes. | $3.9M / Seed / Nov 22, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Ascentifi invest in?
Ascentifi invests primarily in Health Care, Medical Device and Medical startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Ascentifi's check size?
Ascentifi typically joins rounds of $2.3M–$11M at Seed, $9.2M–$34M at Series A and $3M–$3.5M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ascentifi participates in.
When did Ascentifi last invest?
The most recent investment recorded for Ascentifi closed in Apr 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
